EconPapers    
Economics at your fingertips  
 

Small genomic insertions form enhancers that misregulate oncogenes

Brian J. Abraham, Denes Hnisz, Abraham S. Weintraub, Nicholas Kwiatkowski, Charles H. Li, Zhaodong Li, Nina Weichert-Leahey, Sunniyat Rahman, Yu Liu, Julia Etchin, Benshang Li, Shuhong Shen, Tong Ihn Lee, Jinghui Zhang, A. Thomas Look (), Marc R. Mansour () and Richard A. Young ()
Additional contact information
Brian J. Abraham: Whitehead Institute for Biomedical Research
Denes Hnisz: Whitehead Institute for Biomedical Research
Abraham S. Weintraub: Whitehead Institute for Biomedical Research
Nicholas Kwiatkowski: Whitehead Institute for Biomedical Research
Charles H. Li: Whitehead Institute for Biomedical Research
Zhaodong Li: Dana-Farber Cancer Institute, Harvard Medical School
Nina Weichert-Leahey: Dana-Farber Cancer Institute, Harvard Medical School
Sunniyat Rahman: UCL Cancer Institute, University College London
Yu Liu: St Jude Children’s Research Hospital
Julia Etchin: Dana-Farber Cancer Institute, Harvard Medical School
Benshang Li: Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine
Shuhong Shen: Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine
Tong Ihn Lee: Whitehead Institute for Biomedical Research
Jinghui Zhang: St Jude Children’s Research Hospital
A. Thomas Look: Dana-Farber Cancer Institute, Harvard Medical School
Marc R. Mansour: UCL Cancer Institute, University College London
Richard A. Young: Whitehead Institute for Biomedical Research

Nature Communications, 2017, vol. 8, issue 1, 1-13

Abstract: Abstract The non-coding regions of tumour cell genomes harbour a considerable fraction of total DNA sequence variation, but the functional contribution of these variants to tumorigenesis is ill-defined. Among these non-coding variants, somatic insertions are among the least well characterized due to challenges with interpreting short-read DNA sequences. Here, using a combination of Chip-seq to enrich enhancer DNA and a computational approach with multiple DNA alignment procedures, we identify enhancer-associated small insertion variants. Among the 102 tumour cell genomes we analyse, small insertions are frequently observed in enhancer DNA sequences near known oncogenes. Further study of one insertion, somatically acquired in primary leukaemia tumour genomes, reveals that it nucleates formation of an active enhancer that drives expression of the LMO2 oncogene. The approach described here to identify enhancer-associated small insertion variants provides a foundation for further study of these abnormalities across human cancers.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms14385 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14385

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms14385

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14385